相关实验视频
Updated: Jun 25, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
551
乙氨症作为COVID-19在末期病患者中死亡率的预后因素
I Gede Yasa Asmara1, I Gusti Ngurah Ommy Agustriadi1, I Made Sujaya1
1Department of Internal Medicine, Faculty of Medicine, University of Mataram - West Nusa Tenggara General Hospital, Mataram, Indonesia.
Caspian journal of internal medicine
|May 29, 2024
概括
乙素衰弱或低乙素细胞计数是COVID-19患者末期病 (ESKD) 患者死亡率的重要预测因素. 这种情况,连同血液透析,独立增加死亡的风险,在这个脆弱的人群.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
背景情况:
- 埃索诺菲尔在COVID-19中起着已知的作用,但它们在COVID-19患者末期病 (ESKD) 中的重要性尚未得到充分研究.
- 这项研究解决了关于eosinopenia作为ESKD的COVID-19患者死亡率标志物的知识差距.
研究的目的:
- 为了研究患有COVID-19诊断的末期脏病 (ESKD) 患者的死亡率,eosinopenia的预测价值.
- 在ESKD患者中确定COVID-19死亡率的独立预后因素.
主要方法:
- 从2020年5月到2021年10月,对115名患有COVID-19的ESKD患者进行了回顾性研究.
- 进行了幸存者和非幸存者组之间的比较分析,随后进行多变量逻辑回归以确定显著的死亡预测因素.
主要成果:
- 在COVID-19 ESKD患者中,死亡率为25.2%.
- 在未幸存者中 (51.4%) 患有欧氨是普遍存在的.
- 在多变量分析中,确定了乙氨症 (低乙氨基酸计数) 和血液透析是该队列中死亡的独立风险因素.
结论:
- 乙氨是COVID-19患者患有ESKD的常见发现,特别是那些没有生存的人.
- 在住院期间入院时患有乙氨和接受血液透析是ESKD患者COVID-19死亡率的重要风险因素.
相关概念视频
01:27Dialysis
294
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
294
01:11Renal Failure: Dose Adjustments
84
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
84